Bertil Lindmark
Chief Tech/Sci/R&D Officer at VICORE PHARMA HOLDING AB
Net worth: 12 951 $ as of 2024-03-30
Profile
Bertil E.
Lindmark is currently serving as the Chairman of the Board at Aqilion AB.
He is also a Director at Aslan Pharmaceuticals (Shanghai) Co. Ltd., Cellevate AB, and ALK-Abello A.
In addition, he holds the position of Chief Medical Officer at Vicore Pharma Holding AB and is a Venture Partner at Xgen Venture Sgr SpA.
Previously, Dr. Lindmark worked as a Director at Medicon Valley Alliance FMBA.
He also served as the Executive Director & Executive Director-R&D at Almirall SA from 2011 to 2015.
From 2015 to 2019, he held the role of Chief Scientific & Medical Officer at ASLAN Pharmaceuticals Pte Ltd.
Prior to that, he was the Vice President at AstraZeneca Pharma India Ltd.
from 1991 to 2009.
He also served as the Chief Medical Officer at eTheRNA immunotherapies NV from 2018 to 2020 and at Galecto, Inc. from 2020 to 2023.
Additionally, he was the Head-Clinical Development at Astrazeneca Japan Ltd.
from 2009 to 2015.
Dr. Lindmark obtained his doctorate degree from the University of Lund in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GALECTO, INC.
0.06% | 2023-04-16 | 16,604 ( 0.06% ) | 12 951 $ | 2024-03-30 |
Bertil Lindmark active positions
| Companies | Position | Start |
|---|---|---|
| ALK-ABELLÓ A/S | Director/Board Member | 2021-03-17 |
| VICORE PHARMA HOLDING AB | Chief Tech/Sci/R&D Officer | 2023-12-31 |
| Aslan Pharmaceuticals (Shanghai) Co. Ltd. | Director/Board Member | - |
Cellevate AB
 Cellevate AB Miscellaneous Commercial ServicesCommercial Services Cellevate AB is a Swedish biotech company that specializes in developing advanced cell culture systems. The private company is based in Lund, Sweden. The company's patented manufacturing process creates highly porous and consistent networks of nanofibers. Cellevate was founded by Lars Gosta Montelius. | Director/Board Member | 2019-01-31 |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Private Equity Investor | 2022-12-31 |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Chairman | 2022-07-31 |
Former positions of Bertil Lindmark
| Companies | Position | End |
|---|---|---|
| GALECTO, INC. | Chief Tech/Sci/R&D Officer | 2023-09-30 |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Bertil Lindmark
| University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ALMIRALL, S.A. | Health Technology |
| ALK-ABELLÓ A/S | Health Technology |
| ASTRAZENECA PHARMA INDIA LIMITED | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| GALECTO, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Health Services |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Medicon Valley Alliance FMBA operates a life science cluster that spans across Denmark and Sweden. The non-profit company is based in the Medicon Valley region. | Commercial Services |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
| Aslan Pharmaceuticals (Shanghai) Co. Ltd. | |
Cellevate AB
Cellevate AB Miscellaneous Commercial ServicesCommercial Services Cellevate AB is a Swedish biotech company that specializes in developing advanced cell culture systems. The private company is based in Lund, Sweden. The company's patented manufacturing process creates highly porous and consistent networks of nanofibers. Cellevate was founded by Lars Gosta Montelius. | Commercial Services |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |
- Stock Market
- Insiders
- Bertil Lindmark
